Bieche I - Search Results

1

Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines.

Aissat N, Le Tourneau C, Ghoul A, Serova M, Bieche I, Lokiec F, Raymond E, Faivre S. Aissat N, et al. Among authors: bieche i. Cancer Chemother Pharmacol. 2008 Jul;62(2):305-13. doi: 10.1007/s00280-007-0609-2. Epub 2007 Oct 2. Cancer Chemother Pharmacol. 2008. PMID: 17912526

2

mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels.

Ghayad SE, Bieche I, Vendrell JA, Keime C, Lidereau R, Dumontet C, Cohen PA. Ghayad SE, et al. Among authors: bieche i. Cancer Sci. 2008 Oct;99(10):1992-2003. doi: 10.1111/j.1349-7006.2008.00955.x. Cancer Sci. 2008. PMID: 19016759 Free article.

3

Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells.

Ghoul A, Serova M, Astorgues-Xerri L, Bieche I, Bousquet G, Varna M, Vidaud M, Phillips E, Weill S, Benhadji KA, Lokiec F, Cvitkovic E, Faivre S, Raymond E. Ghoul A, et al. Among authors: bieche i. Cancer Res. 2009 May 15;69(10):4260-9. doi: 10.1158/0008-5472.CAN-08-2837. Epub 2009 May 5. Cancer Res. 2009. PMID: 19417139

4

Endocrine resistance associated with activated ErbB system in breast cancer cells is reversed by inhibiting MAPK or PI3K/Akt signaling pathways.

Ghayad SE, Vendrell JA, Ben Larbi S, Dumontet C, Bieche I, Cohen PA. Ghayad SE, et al. Among authors: bieche i. Int J Cancer. 2010 Jan 15;126(2):545-62. doi: 10.1002/ijc.24750. Int J Cancer. 2010. PMID: 19609946 Free article.

5

Epithelial-to-mesenchymal transition and oncogenic Ras expression in resistance to the protein kinase Cbeta inhibitor enzastaurin in colon cancer cells.

Serova M, Astorgues-Xerri L, Bieche I, Albert S, Vidaud M, Benhadji KA, Emami S, Vidaud D, Hammel P, Theou-Anton N, Gespach C, Faivre S, Raymond E. Serova M, et al. Among authors: bieche i. Mol Cancer Ther. 2010 May;9(5):1308-17. doi: 10.1158/1535-7163.MCT-10-0167. Epub 2010 Apr 20. Mol Cancer Ther. 2010. PMID: 20406951

6

Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma.

Marijon H, Dokmak S, Paradis V, Zappa M, Bieche I, Bouattour M, Raymond E, Faivre S. Marijon H, et al. Among authors: bieche i. J Hepatol. 2011 May;54(5):1073-8. doi: 10.1016/j.jhep.2010.11.011. Epub 2010 Dec 2. J Hepatol. 2011. PMID: 21145871 Free article.

7

Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells.

Lovejoy KS, Serova M, Bieche I, Emami S, D'Incalci M, Broggini M, Erba E, Gespach C, Cvitkovic E, Faivre S, Raymond E, Lippard SJ. Lovejoy KS, et al. Among authors: bieche i. Mol Cancer Ther. 2011 Sep;10(9):1709-19. doi: 10.1158/1535-7163.MCT-11-0250. Epub 2011 Jul 12. Mol Cancer Ther. 2011. PMID: 21750216 Free PMC article.

8

Predictive factors of sensitivity to elisidepsin, a novel Kahalalide F-derived marine compound.

Serova M, de Gramont A, Bieche I, Riveiro ME, Galmarini CM, Aracil M, Jimeno J, Faivre S, Raymond E. Serova M, et al. Among authors: bieche i. Mar Drugs. 2013 Mar 20;11(3):944-59. doi: 10.3390/md11030944. Mar Drugs. 2013. PMID: 23519149 Free PMC article.

9

OTX008, a selective small-molecule inhibitor of galectin-1, downregulates cancer cell proliferation, invasion and tumour angiogenesis.

Astorgues-Xerri L, Riveiro ME, Tijeras-Raballand A, Serova M, Rabinovich GA, Bieche I, Vidaud M, de Gramont A, Martinet M, Cvitkovic E, Faivre S, Raymond E. Astorgues-Xerri L, et al. Among authors: bieche i. Eur J Cancer. 2014 Sep;50(14):2463-77. doi: 10.1016/j.ejca.2014.06.015. Epub 2014 Jul 16. Eur J Cancer. 2014. PMID: 25042151

10

Precision medicine: lessons learned from the SHIVA trial - Authors' reply.

Le Tourneau C, Belin L, Paoletti X, Bièche I, Kamal M. Le Tourneau C, et al. Among authors: bieche i. Lancet Oncol. 2015 Dec;16(16):e581-2. doi: 10.1016/S1470-2045(15)00455-6. Lancet Oncol. 2015. PMID: 26678200 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

529 results

Search Page